928 established journals publish at least 20 % of their articles in Molecular Biology. 409 of them are fully open access, and at least 16 of those charge authors nothing (diamond open access). Where open-access journals charge a fee, the median is 2 670 USD. Highest recent citation rates: Nature Reviews Molecular Cell Biology, Cell, Nature Reviews Microbiology.
928 journals
Most relevant first: how much of a journal's work is in Molecular Biology, how many articles it publishes and how often they are cited. Click a column to sort.
| Nucleic Acids ResearchOxford University Press | 82 % | 1 339 | 17.20 | 868 | 3 992 USD |
| Molecular CellElsevier BV | 84 % | 406 | 14.26 | 527 | Subscription; open access option 10 400 USD |
| CellCell Press | 64 % | 498 | 41.44 | 1 217 | Subscription; open access option 11 400 USD |
| BioinformaticsOxford University Press | 77 % | 813 | 6.43 | 558 | 3 989 USD |
| Briefings in BioinformaticsOxford University Press | 75 % | 660 | 7.38 | 209 | 3 885 USD |
| Nature CommunicationsNature Portfolio | 42 % | 9 502 | 18.31 | 744 | 6 990 USD |
| Nature Structural & Molecular BiologyNature Portfolio | 79 % | 237 | 11.19 | 321 | Subscription; open access option 12 690 USD |
| Nature Reviews Molecular Cell BiologyNature Portfolio | 64 % | 123 | 44.24 | 621 | Subscription |
| Nature MethodsNature Portfolio | 58 % | 395 | 24.58 | 504 | Subscription; open access option 12 690 USD |
| Proceedings of the National Academy of SciencesNational Academy of Sciences | 50 % | 4 027 | 8.84 | 1 165 | Subscription |
| Genome biologyBioMed Central | 69 % | 337 | 10.19 | 388 | 5 490 USD |
| Nature Chemical BiologyNature Portfolio | 69 % | 281 | 10.67 | 314 | Subscription; open access option 12 690 USD |
| Computational and Structural Biotechnology JournalElsevier BV | 70 % | 538 | 6.80 | 125 | 3 230 USD |
| BMC BioinformaticsBioMed Central | 77 % | 488 | 4.78 | 306 | 2 990 USD |
| ACS Synthetic BiologyAmerican Chemical Society | 76 % | 407 | 5.14 | 128 | Subscription; open access option 4 500 USD |
| Nature ProtocolsNature Portfolio | 61 % | 169 | 20.80 | 384 | Subscription |
| The EMBO JournalSpringer Nature | 68 % | 311 | 8.48 | 563 | 7 990 USD |
| Cell SystemsElsevier BV | 81 % | 105 | 7.34 | 133 | Subscription; open access option 9 350 USD |
| Biochemical and Biophysical Research CommunicationsElsevier BV | 71 % | 1 435 | 2.73 | 393 | Subscription; open access option 3 110 USD |
| Nature Cell BiologyNature Portfolio | 53 % | 245 | 16.89 | 485 | Subscription; open access option 12 690 USD |
| Trends in Biochemical SciencesElsevier BV | 72 % | 134 | 7.93 | 398 | Subscription; open access option 7 030 USD |
| Current Opinion in Structural BiologyElsevier BV | 66 % | 172 | 8.19 | 251 | Subscription; open access option 4 360 USD |
| Molecular Systems BiologySpringer Nature | 77 % | 78 | 8.04 | 212 | 7 990 USD |
| Metabolic EngineeringElsevier BV | 67 % | 148 | 8.16 | 181 | Subscription; open access option 4 780 USD |
| Cell stem cellElsevier BV | 52 % | 168 | 19.61 | 371 | Subscription; open access option 10 400 USD |
| Cell chemical biologyElsevier BV | 64 % | 157 | 8.28 | 119 | Subscription; open access option 9 350 USD |
| Nature Reviews GeneticsNature Portfolio | 56 % | 120 | 17.17 | 522 | Subscription |
| Journal of Molecular BiologyElsevier BV | 63 % | 403 | 4.95 | 483 | Subscription; open access option 4 730 USD |
| NAR Genomics and BioinformaticsOxford University Press | 78 % | 151 | 4.33 | 49 | 2 766 USD |
| Journal of Extracellular VesiclesTaylor & Francis | 51 % | 149 | 20.79 | 171 | 4 410 USD |
| Cell Death and DifferentiationSpringer Nature | 58 % | 189 | 10.18 | 312 | Subscription; open access option 5 790 USD |
| RNACold Spring Harbor Laboratory Press | 87 % | 131 | 3.38 | 214 | Subscription |
| Developmental CellElsevier BV | 53 % | 257 | 11.21 | 359 | Subscription; open access option 10 400 USD |
| Cell DiscoverySpringer Nature | 57 % | 125 | 14.05 | 99 | 3 590 USD |
| Current Opinion in BiotechnologyElsevier BV | 61 % | 162 | 8.67 | 290 | Subscription; open access option 4 530 USD |
| Redox BiologyElsevier BV | 45 % | 421 | 14.35 | 209 | 4 310 USD |
| OncogeneSpringer Nature | 56 % | 410 | 6.72 | 423 | Subscription; open access option 5 990 USD |
| Journal of Biological ChemistryElsevier BV | 67 % | 2 110 | 1.93 | 780 | 3 430 USD |
| Cellular SignallingElsevier BV | 64 % | 408 | 4.14 | 191 | Subscription; open access option 3 550 USD |
| Genome ResearchCold Spring Harbor Laboratory Press | 59 % | 186 | 8.24 | 399 | Subscription |
| DevelopmentThe Company of Biologists | 64 % | 429 | 3.71 | 468 | Subscription |
| Trends in biotechnologyElsevier BV | 59 % | 193 | 7.73 | 313 | Subscription; open access option 7 030 USD |
| Genes & DevelopmentCold Spring Harbor Laboratory Press | 77 % | 102 | 4.86 | 592 | Open access, fee unknown |
| Epigenetics & ChromatinBioMed Central | 83 % | 55 | 5.98 | 91 | 3 190 USD |
| Cell ReportsCell Press | 41 % | 1 511 | 8.69 | 319 | 5 620 USD |
| FEBS LettersWiley | 72 % | 296 | 2.96 | 392 | Subscription; open access option 3 980 USD |
| BiomoleculesMultidisciplinary Digital Publishing Institute | 42 % | 1 814 | 6.65 | 190 | 3 258 USD |
| American Journal of Physiology-Cell PhysiologyAmerican Physical Society | 60 % | 251 | 5.34 | 270 | Subscription |
| Genomics Proteomics & BioinformaticsElsevier BV | 69 % | 102 | 6.24 | 100 | 3 850 USD |
| RNA BiologyTaylor & Francis | 74 % | 109 | 4.65 | 135 | 3 175 USD |
| Protein ScienceWiley | 65 % | 355 | 3.41 | 250 | Subscription; open access option 4 480 USD |
| Life Science AlliancePublisher unknown | 62 % | 259 | 4.64 | 61 | 3 500 USD |
| MethodsElsevier BV | 71 % | 170 | 3.87 | 203 | Subscription; open access option 3 600 USD |
| Molecular Therapy — Nucleic AcidsCell Press | 57 % | 324 | 5.25 | 128 | 3 900 USD |
| Microbial Cell FactoriesBioMed Central | 52 % | 283 | 7.72 | 167 | 3 590 USD |
| Cell ResearchSpringer Nature | 52 % | 150 | 12.45 | 270 | Subscription; open access option 5 190 USD |
| Cellular & Molecular Biology LettersBioMed Central | 56 % | 118 | 10.54 | 86 | 2 890 USD |
| Biotechnology AdvancesElsevier BV | 50 % | 168 | 11.80 | 301 | Subscription; open access option 5 460 USD |
| Frontiers in Molecular BiosciencesFrontiers Media | 50 % | 951 | 4.47 | 120 | 3 801 USD |
| MetabolitesMultidisciplinary Digital Publishing Institute | 49 % | 988 | 4.40 | 117 | 3 258 USD |
| FEBS JournalWiley | 59 % | 442 | 3.68 | 225 | Subscription; open access option 5 000 USD |
| DNA repairElsevier BV | 69 % | 112 | 4.81 | 154 | Subscription; open access option 3 390 USD |
| PLoS Computational BiologyPublic Library of Science | 48 % | 862 | 4.65 | 282 | 3 043 USD |
| Clinical EpigeneticsBioMed Central | 57 % | 211 | 5.59 | 114 | 3 890 USD |
| IEEE Transactions on Computational Biology and BioinformaticsInstitute of Electrical and Electronics Engineers | 73 % | 247 | 2.49 | 113 | Subscription; open access option 2 645 USD |
| Gut MicrobesLandes Bioscience | 39 % | 311 | 17.14 | 170 | 3 060 USD |
| EMBO ReportsSpringer Nature | 52 % | 326 | 5.57 | 251 | 7 990 USD |
| Wiley Interdisciplinary Reviews - RNAWiley | 81 % | 62 | 4.02 | 119 | Subscription; open access option 4 780 USD |
| Bioinformatics AdvancesOxford University Press | 75 % | 175 | 2.62 | 31 | 2 726 USD |
| Briefings in Functional GenomicsOxford University Press | 74 % | 47 | 6.61 | 84 | Subscription; open access option 3 700 USD |
| iMetaWiley | 47 % | 79 | 23.72 | 63 | 1 320 USD |
| Biochemical Society TransactionsPortland Press | 56 % | 181 | 6.13 | 216 | Subscription |
| Current Opinion in Genetics & DevelopmentElsevier BV | 65 % | 102 | 5.43 | 242 | Subscription; open access option 4 200 USD |
| BMC BiologyBioMed Central | 50 % | 313 | 6.27 | 172 | 3 690 USD |
| StructureElsevier BV | 58 % | 193 | 4.98 | 237 | Subscription; open access option 9 350 USD |
| Stem Cell ReportsElsevier BV | 58 % | 192 | 5.07 | 145 | 4 190 USD |
| Cell Death DiscoverySpringer Nature | 39 % | 502 | 11.32 | 108 | 2 690 USD |
| ChemBioChemWiley | 59 % | 497 | 2.91 | 162 | Subscription; open access option 4 430 USD |
| npj Systems Biology and ApplicationsNature Portfolio | 67 % | 94 | 4.96 | 54 | 3 490 USD |
| Cell Death and DiseaseSpringer Nature | 36 % | 1 011 | 9.56 | 232 | 4 990 USD |
| Trends in GeneticsElsevier BV | 55 % | 140 | 7.26 | 329 | Subscription; open access option 7 030 USD |
| Molecular CancerBioMed Central | 35 % | 245 | 29.52 | 284 | 5 090 USD |
| Biotechnology JournalWiley | 57 % | 214 | 4.75 | 140 | Subscription; open access option 4 780 USD |
| Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchElsevier BV | 61 % | 179 | 4.22 | 247 | Subscription; open access option 3 930 USD |
| Communications BiologyNature Portfolio | 38 % | 1 573 | 6.54 | 141 | 4 190 USD |
| BMC GenomicsBioMed Central | 45 % | 1 021 | 4.49 | 255 | 3 090 USD |
| iScienceCell Press | 39 % | 2 440 | 4.79 | 141 | 3 240 USD |
| International Journal of Molecular SciencesMultidisciplinary Digital Publishing Institute | 28 % | 14 723 | 6.99 | 424 | 3 499 USD |
| Cell GenomicsElsevier BV | 52 % | 120 | 9.38 | 58 | 8 900 USD |
| Molecular BiotechnologySpringer Science+Business Media | 57 % | 246 | 4.07 | 110 | Subscription; open access option 3 790 USD |
| GigaScienceUniversity of Oxford | 50 % | 129 | 10.06 | 133 | 2 638 USD |
| EpigeneticsLandes Bioscience | 68 % | 88 | 4.29 | 136 | Open access, fee unknown |
| Nature GeneticsNature Portfolio | 35 % | 340 | 19.09 | 775 | Subscription; open access option 12 690 USD |
| Frontiers in Cell and Developmental BiologyFrontiers Media | 39 % | 2 023 | 4.76 | 171 | 3 801 USD |
| CellsMultidisciplinary Digital Publishing Institute | 33 % | 2 957 | 6.78 | 232 | 3 258 USD |
| Trends in Cell BiologyElsevier BV | 49 % | 132 | 9.60 | 320 | Subscription; open access option 7 030 USD |
| BiochimieElsevier BV | 64 % | 208 | 3.07 | 203 | Subscription; open access option 3 110 USD |
| APOPTOSISSpringer Science+Business Media | 57 % | 110 | 6.40 | 148 | Subscription; open access option 5 090 USD |
| BiochemistryAmerican Chemical Society | 59 % | 392 | 2.79 | 442 | Subscription; open access option 4 500 USD |
| Cell Stress and ChaperonesSpringer Science+Business Media | 65 % | 71 | 5.67 | 117 | 2 850 USD |
| Molecular and Cellular BiochemistrySpringer Science+Business Media | 53 % | 290 | 4.35 | 171 | Subscription; open access option 4 190 USD |
| Journal of Ginseng Researchdiamond OAElsevier BV | 63 % | 80 | 5.39 | 84 | None (diamond OA) |
| Annual Review of BiochemistryAnnual Reviews | 57 % | 25 | 26.49 | 539 | Subscription |
| Cell Communication and SignalingBioMed Central | 39 % | 384 | 10.30 | 133 | 3 390 USD |
| Archives of Biochemistry and BiophysicsElsevier BV | 55 % | 283 | 3.66 | 295 | Subscription; open access option 3 170 USD |
| Biochimica et Biophysica Acta (BBA) - Gene Regulatory MechanismsElsevier BV | 81 % | 53 | 3.24 | 136 | Subscription; open access option 3 840 USD |
| Molecular and Cellular BiologyTaylor & Francis | 78 % | 67 | 3.12 | 458 | Subscription |
| Journal of Biomolecular Structure and DynamicsTaylor & Francis | 52 % | 763 | 2.74 | 123 | Subscription |
| Seminars in Cell and Developmental BiologyElsevier BV | 57 % | 151 | 4.67 | 205 | Subscription; open access option 4 670 USD |
| Science SignalingAmerican Association for the Advancement of Science | 52 % | 156 | 5.90 | 193 | Subscription |
| Synthetic and Systems BiotechnologyElsevier BV | 62 % | 108 | 4.37 | 55 | 1 500 USD |
| Free Radical Biology and MedicineElsevier BV | 43 % | 1 083 | 3.94 | 378 | Subscription; open access option 4 240 USD |
| MitochondrionElsevier BV | 59 % | 96 | 5.28 | 129 | Subscription; open access option 3 220 USD |
| Cell Reports MethodsElsevier BV | 55 % | 156 | 5.02 | 43 | 4 824 USD |
| GeneElsevier BV | 49 % | 683 | 3.15 | 301 | Subscription; open access option 3 300 USD |
| npj Biofilms and MicrobiomesNature Portfolio | 45 % | 143 | 10.48 | 93 | 4 290 USD |
| ACS Chemical BiologyAmerican Chemical Society | 52 % | 321 | 3.79 | 166 | Subscription; open access option 4 500 USD |
| Nature reviews. CancerNature Portfolio | 38 % | 115 | 26.63 | 595 | Subscription |
| EpigenomicsFuture Medicine | 66 % | 121 | 3.22 | 94 | Subscription |
| Science China Life SciencesSpringer Science+Business Media | 48 % | 253 | 5.56 | 106 | Subscription; open access option 3 790 USD |
| BioDesign ResearchAmerican Association for the Advancement of Science | 72 % | 23 | 8.72 | 26 | 2 500 USD |
| Current Opinion in Chemical BiologyElsevier BV | 51 % | 100 | 7.62 | 228 | Subscription; open access option 4 510 USD |
| MicrobiomeBioMed Central | 35 % | 270 | 15.14 | 230 | 4 990 USD |
| Molecules and CellsSpringer Science+Business Media | 52 % | 101 | 6.95 | 116 | 2 500 USD |
| Biochemistry (Moscow)Pleiades Publishing | 68 % | 274 | 1.82 | 106 | Subscription |
| MetabolomicsSpringer Science+Business Media | 61 % | 133 | 3.55 | 121 | Subscription; open access option 3 890 USD |
| Experimental & Molecular MedicineSpringer Nature | 37 % | 213 | 14.67 | 180 | 4 490 USD |
| Critical Reviews in Biochemistry and Molecular BiologyTaylor & Francis | 76 % | 18 | 8.88 | 188 | Subscription |
| Current ProtocolsWiley | 62 % | 292 | 2.23 | 47 | Subscription; open access option 4 890 USD |
| Biochemical JournalPortland Press | 56 % | 150 | 4.12 | 401 | Subscription |
| International Journal of Biological SciencesIvyspring International Publisher | 36 % | 371 | 10.56 | 164 | 1 337 USD |
| Cellular and Molecular Life SciencesSpringer Nature | 38 % | 454 | 7.18 | 328 | 4 290 USD |
| Experimental Cell ResearchElsevier BV | 51 % | 328 | 3.48 | 285 | Subscription; open access option 3 270 USD |
| FEMS Yeast ResearchOxford University Press | 66 % | 62 | 4.41 | 128 | 3 297 USD |
| The International Journal of Biochemistry & Cell BiologyElsevier BV | 61 % | 116 | 3.58 | 238 | Subscription; open access option 3 840 USD |
| Open BiologyRoyal Society | 54 % | 133 | 4.72 | 109 | 1 839 USD |
| Biosensors and BioelectronicsElsevier BV | 30 % | 915 | 11.27 | 286 | Subscription; open access option 5 540 USD |
| The Journal of Cell BiologyRockefeller University Press | 42 % | 275 | 6.77 | 596 | Subscription |
| PLoS GeneticsPublic Library of Science | 44 % | 445 | 4.57 | 341 | 3 043 USD |
| The FASEB JournalWiley | 37 % | 2 602 | 3.49 | 401 | Subscription; open access option 3 740 USD |
| BioEssaysWiley | 52 % | 186 | 3.98 | 255 | Subscription; open access option 5 330 USD |
| Applied Microbiology and BiotechnologySpringer Science+Business Media | 37 % | 523 | 7.12 | 331 | 4 190 USD |
| Current Opinion in Cell BiologyElsevier BV | 49 % | 109 | 6.85 | 332 | Subscription; open access option 4 390 USD |
| Nucleic Acid TherapeuticsMary Ann Liebert, Inc. | 72 % | 35 | 4.79 | 64 | Subscription |
| Protein and Peptide LettersBentham Science Publishers | 58 % | 90 | 4.56 | 74 | Subscription |
| NucleusTaylor & Francis | 76 % | 22 | 5.88 | 72 | 1 993 USD |
| Antioxidants and Redox SignalingMary Ann Liebert, Inc. | 51 % | 117 | 5.66 | 273 | Subscription |
| DatabaseUniversity of Oxford | 60 % | 104 | 3.72 | 107 | 2 729 USD |
| NAR CancerOxford University Press | 60 % | 55 | 5.64 | 35 | 2 583 USD |
| EpigenomesMultidisciplinary Digital Publishing Institute | 70 % | 41 | 4.42 | 30 | 1 810 USD |
778 more journals publish in Molecular Biology; the analysis of your paper considers all of them.
Which of these fit your paper?
Paste your title and abstract and get these journals ranked for your work, with the closest published articles as evidence. Free, and your abstract is never stored.
Journals in CWTS Journal Indicators Core or the Directory of Open Access Journals that published at least 20 articles in the last five years, mostly in English. "In this field" is the share of a journal's articles that OpenAlex classifies in Molecular Biology. Citation rate is OpenAlex's two-year mean citedness, an open measure similar to the journal impact factor. Fees are taken from OpenAlex and DOAJ and can be out of date: always check the journal's own website before you submit.